DE69232568D1 - Cyclische Harnstoffe und Analoga verwendbar als retrovirale Proteasehemmer - Google Patents
Cyclische Harnstoffe und Analoga verwendbar als retrovirale ProteasehemmerInfo
- Publication number
- DE69232568D1 DE69232568D1 DE69232568T DE69232568T DE69232568D1 DE 69232568 D1 DE69232568 D1 DE 69232568D1 DE 69232568 T DE69232568 T DE 69232568T DE 69232568 T DE69232568 T DE 69232568T DE 69232568 D1 DE69232568 D1 DE 69232568D1
- Authority
- DE
- Germany
- Prior art keywords
- analogs
- protease inhibitors
- cyclic ureas
- retroviral protease
- retroviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
- C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/06—Seven-membered rings having the hetero atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/04—Seven-membered rings not condensed with other rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77649191A | 1991-10-11 | 1991-10-11 | |
US88394492A | 1992-05-15 | 1992-05-15 | |
US95327292A | 1992-09-29 | 1992-09-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69232568D1 true DE69232568D1 (de) | 2002-05-23 |
DE69232568T2 DE69232568T2 (de) | 2002-12-19 |
Family
ID=27419722
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69221309T Expired - Fee Related DE69221309T2 (de) | 1991-10-11 | 1992-10-13 | Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer |
DE69232568T Expired - Fee Related DE69232568T2 (de) | 1991-10-11 | 1992-10-13 | Cyclische Harnstoffe und Analoga verwendbar als retrovirale Proteasehemmer |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69221309T Expired - Fee Related DE69221309T2 (de) | 1991-10-11 | 1992-10-13 | Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer |
Country Status (19)
Country | Link |
---|---|
EP (3) | EP0765873B1 (de) |
JP (1) | JP3208140B2 (de) |
KR (1) | KR100268694B1 (de) |
AT (2) | ATE216371T1 (de) |
AU (2) | AU2871592A (de) |
BR (1) | BR9206623A (de) |
CA (1) | CA2120925A1 (de) |
CZ (1) | CZ284872B6 (de) |
DE (2) | DE69221309T2 (de) |
DK (1) | DK0607334T3 (de) |
ES (1) | ES2104946T3 (de) |
FI (1) | FI941649A (de) |
GR (1) | GR3025005T3 (de) |
HK (1) | HK1002257A1 (de) |
HU (1) | HU221816B1 (de) |
NO (1) | NO306720B1 (de) |
RU (1) | RU2131420C1 (de) |
SK (1) | SK280882B6 (de) |
WO (1) | WO1993007128A1 (de) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5610294A (en) * | 1991-10-11 | 1997-03-11 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
USRE37781E1 (en) | 1991-10-11 | 2002-07-02 | Dupont Pharmaceuticals Company | Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
DK0656887T3 (da) | 1992-08-25 | 1999-07-05 | Searle & Co | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser |
AU703962B2 (en) * | 1993-02-26 | 1999-04-01 | Du Pont Pharmaceuticals Company | Substituted cyclic carbonyls and derivatives |
US5637780A (en) | 1993-03-30 | 1997-06-10 | The Dupont Merck Pharmaceutical Company | Method for preparing alkylating agents and their use for alkylating cyclic ureas |
JPH09500120A (ja) * | 1993-07-14 | 1997-01-07 | チバ−ガイギー アクチェンゲゼルシャフト | 環式ヒドラジン化合物 |
US5616578A (en) * | 1993-08-26 | 1997-04-01 | The Dupont Merck Pharmaceutical Company | Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor |
IL110752A (en) * | 1993-09-13 | 2000-07-26 | Abbott Lab | Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor |
US5559158A (en) * | 1993-10-01 | 1996-09-24 | Abbott Laboratories | Pharmaceutical composition |
US5559110A (en) * | 1994-03-09 | 1996-09-24 | The Dupont Merck Pharmaceutical Company | Pharmaceutical formulations of cyclic urea type compounds |
US5508400A (en) * | 1994-04-20 | 1996-04-16 | The Du Pont Merck Pharmaceutical Company | Preparation of cyclic urea compounds |
IL129871A (en) * | 1994-05-06 | 2003-11-23 | Pharmacia & Upjohn Inc | Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections |
DE4422911A1 (de) | 1994-06-30 | 1996-01-04 | Hoechst Ag | Phosphinsäure-Derivate, deren Herstellung sowie deren Verwendung |
US5530124A (en) * | 1994-06-30 | 1996-06-25 | The Dupont Merck Pharmaceutical Company | Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors |
US5466797A (en) * | 1994-06-30 | 1995-11-14 | The Du Pont Merck Pharmaceutical Company | Intermediates for the preparation of cyclic urea |
US5705524A (en) * | 1994-11-04 | 1998-01-06 | Gilead Sciences, Inc. | Thiepane compounds |
US6034118A (en) * | 1994-11-04 | 2000-03-07 | Gilead Sciences, Inc. | Thiepane compounds |
AU710492B2 (en) * | 1994-11-04 | 1999-09-23 | Gilead Sciences, Inc. | Thiepane compounds inhibiting and detecting HIV protease |
AU5310096A (en) * | 1995-03-17 | 1996-10-08 | Du Pont Merck Pharmaceutical Company, The | Cyclic urea hiv protease inhibitors |
US5683999A (en) * | 1995-03-17 | 1997-11-04 | The Dupont Merck Pharmaceutical Company | Cyclic urea HIV protease inhibitors |
US5532356A (en) * | 1995-06-06 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Method for preparing N,N'-disubstituted cyclic ureas |
US5532357A (en) * | 1995-06-07 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas |
US6037157A (en) | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
WO1997008150A1 (en) * | 1995-08-22 | 1997-03-06 | The Du Pont Merck Pharmaceutical Company | Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors |
US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
JP3118467B2 (ja) | 1996-03-29 | 2000-12-18 | ファイザー インク. | 5―ht1aおよび/または5―ht1d受容体の選択的(アンタ)アゴニストとしてのベンジル(イデン)―ラクタム誘導体、その調製法及びその使用法 |
US6063794A (en) | 1996-10-11 | 2000-05-16 | Cor Therapeutics Inc. | Selective factor Xa inhibitors |
US6262047B1 (en) | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6194435B1 (en) | 1996-10-11 | 2001-02-27 | Cor Therapeutics, Inc. | Lactams as selective factor Xa inhibitors |
US6369080B2 (en) | 1996-10-11 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
SI9720071A (sl) * | 1996-11-08 | 1999-12-31 | Dupont Pharmaceuticals Company | 1-(3-aminoindazol-5-il)-3-butil-ciklična sečnina, uporabna kot inhibitor proteaze HIV |
ZA979868B (en) | 1996-11-08 | 1999-05-03 | Du Pont Merck Pharma | A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor |
ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
US6232333B1 (en) | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
WO1998046626A1 (en) | 1997-04-14 | 1998-10-22 | Cor Therapeutics, Inc. | SELECTIVE FACTOR Xa INHIBITORS |
JP2001521524A (ja) * | 1997-04-14 | 2001-11-06 | シーオーアール セラピューティクス インコーポレイテッド | 選択的Xa因子阻害剤 |
EP0975625A1 (de) | 1997-04-14 | 2000-02-02 | Cor Therapeutics, Inc. | AUSWÄHLEND Xa KAKTOR INHIBITOREN |
US6369063B1 (en) | 1997-04-14 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6333321B1 (en) | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6228854B1 (en) | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6218382B1 (en) | 1997-08-11 | 2001-04-17 | Cor Therapeutics, Inc | Selective factor Xa inhibitors |
KR19990016003A (ko) * | 1997-08-12 | 1999-03-05 | 성재갑 | 치토크롬 저해제 조성물 |
KR100348561B1 (ko) * | 1997-08-12 | 2002-09-18 | 주식회사 엘지씨아이 | Lb71350과 dmp450을 함유하는 조성물 |
US6313110B1 (en) | 1999-06-02 | 2001-11-06 | Dupont Pharmaceuticals Company | Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor |
DE19962923A1 (de) * | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Benzoylcyclohexandione |
EP2269591B1 (de) | 2000-01-19 | 2018-04-04 | AbbVie Inc. | Verbesserte pharmazeutische zusammensetzungen |
FR2810039B1 (fr) | 2000-06-13 | 2007-05-25 | Centre Nat Rech Scient | Composes urees cycliques et leur procede de preparation |
UA76977C2 (en) | 2001-03-02 | 2006-10-16 | Icos Corp | Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers |
WO2004011429A1 (ja) * | 2002-07-26 | 2004-02-05 | Nihon Nohyaku Co., Ltd. | 新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法 |
JP2004107323A (ja) * | 2002-07-26 | 2004-04-08 | Nippon Nohyaku Co Ltd | 新規なハロアルキルスルホンアニリド誘導体及び除草剤並びにその使用方法 |
US7834043B2 (en) | 2003-12-11 | 2010-11-16 | Abbott Laboratories | HIV protease inhibiting compounds |
US7777030B2 (en) | 2005-12-29 | 2010-08-17 | Centre National de la Recherge Scientifique (CNRS) | Compositions and methods for the treatment and prevention of disease |
EP2125750B1 (de) | 2007-02-26 | 2014-05-21 | Vitae Pharmaceuticals, Inc. | Zyklische harnstoff- und carbamat-hemmer aus 11-beta-hydroxysteroid-dehydrogenase 1 |
US8598364B2 (en) | 2007-03-12 | 2013-12-03 | Nektar Therapeutics | Oligomer-protease inhibitor conjugates |
AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
US8440658B2 (en) | 2007-12-11 | 2013-05-14 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
WO2009114151A1 (en) | 2008-03-12 | 2009-09-17 | Nektar Therapeutics | Oligomer-amino acid and olgomer-atazanavir conjugates |
CA2729998A1 (en) | 2008-07-25 | 2010-01-28 | Boehringer Ingelheim International Gmbh | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
RU2539979C2 (ru) | 2008-07-25 | 2015-01-27 | Вайтаи Фармасьютиклз, Инк. | Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1 |
CA2744946A1 (en) | 2009-02-04 | 2010-08-12 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
UA109255C2 (ru) | 2009-04-30 | 2015-08-10 | Берінгер Інгельхайм Інтернешнл Гмбх | Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1 |
JP5656986B2 (ja) | 2009-06-11 | 2015-01-21 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 1,3−オキサジナン−2−オン構造に基づく11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤 |
WO2010144869A2 (en) | 2009-06-12 | 2010-12-16 | Nektar Therapeutics | Protease inhibitors |
CN102596904B (zh) * | 2009-06-26 | 2015-01-28 | 佛罗里达大学研究基金会公司 | 蛋白酶抑制剂、组合物及使用方法 |
EP2448928B1 (de) | 2009-07-01 | 2014-08-13 | Vitae Pharmaceuticals, Inc. | CYCLISCHE 11ß-HYDROXYSTEROID-DEHYDROGENASE-1-HEMMER |
JP5860042B2 (ja) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用 |
EP2585444B1 (de) | 2010-06-25 | 2014-10-22 | Boehringer Ingelheim International GmbH | Azaspirohexanone als 11-beta-hsd1-hemmer zur behandlung von stoffwechselerkrankungen |
ES2560842T3 (es) * | 2010-10-13 | 2016-02-23 | Abbvie Bahamas Ltd. | Un derivado de 1-fenil-2,5-dibenzimidazol-5-il-pirrolidina antiviral |
CA2813671A1 (en) | 2010-11-02 | 2012-05-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
US4652552A (en) | 1984-09-10 | 1987-03-24 | E. I. Du Pont De Nemours And Company | Tetrapeptide methyl ketone inhibitors of viral proteases |
US4644055A (en) | 1984-12-17 | 1987-02-17 | E. I. Du Pont De Nemours And Company | Method for preparing specific inhibitors of virus-specified proteases |
US4837204A (en) | 1985-01-23 | 1989-06-06 | Abbott Laboratories | Functionalized peptidyl aminodiols and -triols |
FR2600252A1 (fr) | 1986-06-19 | 1987-12-24 | Inst Nat Sante Rech Med | Medicament et composition medicamenteuse pour le traitement de maladies infectieuses dues aux virus, ainsi que pour le traitement des tumeurs |
IL90218A0 (en) | 1988-05-13 | 1989-12-15 | Abbott Lab | Retroviral protease inhibitors |
EP0374097A3 (de) | 1988-12-15 | 1991-06-12 | Ciba-Geigy Ag | Verwendung von Peptidisosteren als retrovirale Proteasehemmer |
US5049548A (en) | 1989-03-03 | 1991-09-17 | Merck & Co., Inc. | Renin-inhibitory di-, tri-, and tetrapeptides |
CA2010531A1 (en) | 1989-03-06 | 1990-09-06 | Werner Neidhart | Amino acid derivatives |
CA2032259A1 (en) | 1989-12-18 | 1991-06-19 | Wayne J. Thompson | Hiv protease inhibitors useful for the treatment of aids |
CA2026832A1 (fr) | 1990-10-03 | 1992-04-04 | Nouredine Haouas | Systeme demontable d'attache rapide pour objets tridimensionnels entre eux |
-
1992
- 1992-10-13 EP EP96118182A patent/EP0765873B1/de not_active Expired - Lifetime
- 1992-10-13 EP EP92922262A patent/EP0607334B1/de not_active Expired - Lifetime
- 1992-10-13 DE DE69221309T patent/DE69221309T2/de not_active Expired - Fee Related
- 1992-10-13 AU AU28715/92A patent/AU2871592A/en not_active Abandoned
- 1992-10-13 EP EP01119426A patent/EP1153921A3/de not_active Withdrawn
- 1992-10-13 AT AT96118182T patent/ATE216371T1/de not_active IP Right Cessation
- 1992-10-13 BR BR9206623A patent/BR9206623A/pt not_active Application Discontinuation
- 1992-10-13 JP JP50724493A patent/JP3208140B2/ja not_active Expired - Fee Related
- 1992-10-13 SK SK407-94A patent/SK280882B6/sk unknown
- 1992-10-13 KR KR1019940701169A patent/KR100268694B1/ko not_active IP Right Cessation
- 1992-10-13 CZ CZ94814A patent/CZ284872B6/cs not_active IP Right Cessation
- 1992-10-13 ES ES92922262T patent/ES2104946T3/es not_active Expired - Lifetime
- 1992-10-13 CA CA002120925A patent/CA2120925A1/en not_active Abandoned
- 1992-10-13 RU RU94031126/04A patent/RU2131420C1/ru not_active IP Right Cessation
- 1992-10-13 HU HU9401020A patent/HU221816B1/hu not_active IP Right Cessation
- 1992-10-13 AT AT92922262T patent/ATE156123T1/de not_active IP Right Cessation
- 1992-10-13 WO PCT/US1992/008749 patent/WO1993007128A1/en active IP Right Grant
- 1992-10-13 DK DK92922262.8T patent/DK0607334T3/da active
- 1992-10-13 DE DE69232568T patent/DE69232568T2/de not_active Expired - Fee Related
-
1994
- 1994-04-08 FI FI941649A patent/FI941649A/fi unknown
- 1994-04-08 NO NO941278A patent/NO306720B1/no not_active IP Right Cessation
- 1994-05-02 AU AU61808/94A patent/AU694417B2/en not_active Ceased
-
1997
- 1997-10-09 GR GR970402648T patent/GR3025005T3/el unknown
-
1998
- 1998-01-23 HK HK98100641A patent/HK1002257A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69232568D1 (de) | Cyclische Harnstoffe und Analoga verwendbar als retrovirale Proteasehemmer | |
DE69332616T2 (de) | Hemmer der retroviralen Protease | |
NO934719L (no) | Hemmere av HIV-protease som er nyttige for behandling av AIDS | |
DE69332002T2 (de) | Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: BRISTOL-MYERS SQUIBB PHARMA CO., PRINCETON, N.J., |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |